动态血糖监测结合CSII治疗老年脆性糖尿病的临床疗效

doi:10.3969/j.issn.1671-7171.2021.05.031

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1122 KB) HTML (0 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】 To analyze the effect of dynamic blood glucose monitoring combined with continuous subcutaneous insulin injection (CSII) in the treatment of elderly brittle diabetes mellitus. 【Methods】 A total of 94 elderly patients with brittle diabetes mellitus in our hospital were enrolled between September 2018 and September 2020. They were randomly divided into the control group and the observation group with 47 cases in each group by the random number table method. All patients were treated with CSII to control blood glucose. On this basis, patients in the control group received eight-stage fingertip blood glucose monitoring while patients in the observation group received dynamic blood glucose monitoring. The clinical efficacy, blood glucose compliance (time of blood glucose compliance, insulin dosage), blood glucose steady-state indicators before treatment and after 7 d of treatment [standard deviation of blood glucose (SDBG), largest amplitude of glycemic excursions (LAGE), mean of daily differences (MODD), fasting plasma glucose coefficient of variation (FPG-CV), postprandial glucose excursion (PPGE)] and occurrence of hypoglycemia were compared between the two groups. 【Results】 After 7 days of treatment, the total effective rate was 97.87% (46/47) and 78.72%(37/47), respectively, in the observation group and in the control group. The total effective rate of treatment in observation group was higher than that in control group (P<0.05) and the difference was statistically significant (χ²=8.340,P=0.004). The time of blood glucose compliance and insulin dosage in observation group were 3.53±1.14 d and 32.83±3.56 U/d, respectively, which were lower than those in control group (6.39±1.35 d and 41.02±3.76, respectively). The differences were statistically significant (t=11.097, 10.844, P<0.05). The SDBG, LAGE, MODD, FPG-CV and PPGE after 7 d of treatment in the two groups were decreased compared to those before treatment, and the above indexes of observation group were lower than those of control group (P<0.05). The incidence rates of hypoglycemia events and unperceived hypoglycemia events in observation group were 2.02±0.65 times/person and 0.54±0.19 times/person, which were lower than those in control group (4.31±1.09 times/person and 1.70±0.53 times/person, perspectively) (P<0.05). 【Conclusion】 Dynamic blood glucose monitoring combined with CSII has a definite efficacy on elderly brittle diabetes mellitus. It can improve blood glucose fluctuations and reduce hypoglycemia events.

Key words： Diabetes Mellitus/TH Blood Glucose /AN Insulin/AD Aged

Received: 23 March 2021

PACS:

R587.1

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	HE Qiu-fen
	LI Hua
	YAN Ge

Cite this article:

HE Qiu-fen,LI Hua,YAN Ge. Effect Analysis of Dynamic Blood Glucose Monitoring Combined with CSII in the Treatment of Elderly Brittle Diabetes Mellitus[J]. JOURNAL OF CLINICAL RESEARCH, 2021, 38(5): 747-749.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2021.05.031 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2021/V38/I5/747

[1] 董玲,靳秋露,马洪飞,等.老年脆性糖尿病多学科联合诊治的意义[J].齐鲁医学杂志,2017,4(175):85-87.
[2] 基于动态血糖监测系统探讨短期持续胰岛素皮下输注在老年2型糖尿病患者中的应用价值[J].实用药物与临床,2020,23(3):242-246.
[3] 黄贵锐,孙国明.2型糖尿病肾病患者血清胆红素及血尿酸水平的变化及意义[J].医学临床研究,2019,36(6):1066-1068.
[4] 张秋菊,陈宝光,秦莉,等.基础联合餐时胰岛素类似物治疗脆性糖尿病的临床观察[J].中国医刊,2017,52(7):38-40.
[5] 孙蔚,陆志强,卞华.成人脆性1型糖尿病持续皮下胰岛素输注的基础率探讨[J].中华内分泌代谢杂志,2017,33(10):828-832.
[6] 沈丽芳.3C整合系统胰岛素泵在2型糖尿病患者中的应用[J].实用临床医药杂志,2017,21(24):145-146.
[7] MANTAJ U, GUTAJ P, OZEGOWSKA K,et al. Continuous subcutaneous insulin infusion reduces neonatal risk in pregnant women with type 1 diabetes mellitus[J].Ginekologia polska,2019, 90(3):154-160.
[8] BENKHADRA K, ALAHDAB F, TAMHANE S U,et al. Continuous subcutaneous insulin infusion versus multiple daily injections in individuals with type 1 diabetes: a systematic review and meta-analysis[J].Endocrine,2017, 55(1):1-8.
[9] 邓琳玲,罗玲,林潭发,等.3C疗法对2型糖尿病患者血糖波动控制的效果研究[J].现代医学,2020,48(2):82-86.
[10] SUHAIL A, RANA A A, BILAL A Q,et al. Myocardial protection with Glucose-Insulin-Potassium infusion during adult cardiac surgery[J].Pak J Med Sci,2017, 33(2):325-329.
[11] 严婕妮,陈阳,杨涛.1型糖尿病的非胰岛素辅助降糖治疗[J].中国实用内科杂志,2020,40(1):11-18.
[12] 张幽幽,陶海英,金都,等.应用722实时动态胰岛素泵系统监测血糖变化的临床分析[J].中华全科医学,2018,16(12):2024-2027.
[13] 王姝琴.动态血糖监测在胰岛素泵治疗糖尿病患者中的应用分析[J].湖南师范大学学报(医学版),2018,15(6):53-56.